Cargando…
COVID-19 in immunocompromised children and adolescents
Since coronavirus disease 2019 (COVID-19) became a global pandemic, concerns have arisen regarding the risks of COVID-19 in immunocompromised children and adolescents. Here we aimed to evaluate the clinical outcomes and risks of severe COVID-19 in immunocompromised pediatric patients. Previous studi...
Autores principales: | Kwak, Byung Ok, Eun, Byung Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167403/ https://www.ncbi.nlm.nih.gov/pubmed/37070297 http://dx.doi.org/10.3345/cep.2022.00878 |
Ejemplares similares
-
Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022) -
The clinical follow-up and management of COVID-19 in children and adolescents with an immunocompromised state or a malignancy
por: ERBAŞ, İrem Ceren, et al.
Publicado: (2022) -
Aspergillus Tracheobronchitis in a Mild Immunocompromised Host
por: Cho, Byung Ha, et al.
Publicado: (2014) -
Long-COVID in immunocompromised children
por: Kuczborska, Karolina, et al.
Publicado: (2022) -
Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)